Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

Market Cap	99.61B -0.4%
Revenue (ttm)	77.80B -18.6%
Net Income	12.94B -41.4%
EPS	2,120.00 -41.4%
Shares Out	6.10M
PE Ratio	7.70
Forward PE	n/a
Dividend	850.00 (5.31%)
Ex-Dividend Date	Dec 29, 2025

Volume	10,888
Average Volume	7,905
Open	16,320
Previous Close	16,320
Day's Range	16,000 - 16,440
52-Week Range	14,730 - 19,250
Beta	n/a
RSI	55.24
Earnings Date	May 19, 2026

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con...

• Founded: 1945
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009300

Financial Performance

In 2025, Sam-A Pharm.'s revenue was 77.80 billion, a decrease of -18.60% compared to the previous year's 95.58 billion. Earnings were 12.94 billion, a decrease of -41.39%.